Immune Design CS (IMDZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMDZ | AQST | NBTX | ||
| Company | Immune Design CS | Aquestive Therapeutics Inc | Nanobiotix S.A. ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.84 | 3.93 | 5.91 | ||
| High | 5.85 | 4.01 | 5.91 | ||
| Low | 5.84 | 3.78 | 5.91 | ||
| Last | 5.85 | 3.93 | 5.91 | ||
| Change | unch | +0.03 | +0.01 | ||
| % Change | unch | +0.77% | +0.17% | ||
| Volume | 103,800 | 1,935,900 | 400 | ||
| 20-Day Average Volume | 409,005 | 2,672,905 | 91,045 | ||
| Previous Close | 5.85 | 3.90 | 5.90 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 5.84 | 4.11 | 5.96 | ||
| 20-Day Raw Stochastic | 100.00% | 25.61% | 53.06% | ||
| 20-Day Relative Strength | 88.63% | 48.31% | 46.56% | ||
| Weighted Alpha | -20.50 | +80.54 | -16.88 | ||
| Today's Opinion | 88% Buy | 56% Buy | 100% Sell | ||
| Previous Opinion | 88% Buy | 72% Buy | 100% Sell | ||
| Last Month's Opinion | 56% Buy | 80% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/25/19 | -12.67% since 04/18/24 | +7.45% since 04/18/24 | ||
| Low | 5.84 on 04/01/19 | 3.78 on 04/25/24 | 5.20 on 04/19/24 | ||
| High | 5.85 on 04/01/19 | 4.54 on 04/19/24 | 6.27 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | +0.34% since 03/01/19 | -5.98% since 03/25/24 | -3.43% since 03/25/24 | ||
| Low | 5.82 on 03/14/19 | 3.72 on 04/16/24 | 5.13 on 04/17/24 | ||
| High | 5.85 on 04/01/19 | 4.54 on 04/19/24 | 6.60 on 04/05/24 | ||
| 3-Month | |||||
| %Chg | +350.00% since 12/31/18 | +65.82% since 01/25/24 | -20.14% since 01/25/24 | ||
| Low | 1.22 on 01/03/19 | 2.33 on 01/26/24 | 5.13 on 04/17/24 | ||
| High | 5.85 on 04/01/19 | 6.23 on 03/18/24 | 8.43 on 01/30/24 | ||
| 6-Month | |||||
| %Chg | +73.08% since 10/01/18 | +180.71% since 10/25/23 | -5.44% since 10/25/23 | ||
| Low | 1.10 on 12/24/18 | 1.37 on 10/26/23 | 5.00 on 11/02/23 | ||
| High | 5.85 on 04/01/19 | 6.23 on 03/18/24 | 8.96 on 01/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 282,935 | 285,874 | 278,085 | ||
| Shares Outstanding, K | 48,365 | 73,301 | 47,133 | ||
| Annual Sales | 2,200,000 | 50,580,000 | 5,030,000 | ||
| Annual Net Income | -54,760,000 | -7,870,000 | -60,100,000 | ||
| Last Quarter Sales | 480,000 | 13,210,000 | N/A | ||
| Last Quarter Net Income | -13,600,000 | -8,110,000 | N/A | ||
| 60-Month Beta | 3.48 | 2.87 | 0.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.12 on 03/05/24 | N/A | ||
| Latest Earnings Date | 05/01/19 | 05/07/24 | 04/22/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||